Your browser doesn't support javascript.
Are Migraine Patients at Increased Risk for Symptomatic Coronavirus Disease 2019 Due to Shared Comorbidities?
Bolay, Hayrunnisa; Özge, Aynur; Uludüz, Derya; Baykan, Betül.
  • Bolay H; Department of Neurology and Algology, Medical Faculty, Gazi University, Ankara, Turkey.
  • Özge A; Department of Neurology and Algology, Medical Faculty, Mersin University, Mersin, Turkey.
  • Uludüz D; Department of Neurology and Algology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.
  • Baykan B; Department of Neurology, Headache Center, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Headache ; 60(10): 2508-2521, 2020 11.
Article in English | MEDLINE | ID: covidwho-894754
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has rapidly transformed the whole world and forced us to look through comorbid diseases and risk factors from a different perspective. COVID-19 shows some inherent risk factors like cardiovascular comorbidities independent from age, gender, and geographic location. One of the most peculiar features of the COVID-19 pandemic is that severe acute respiratory syndrome coronavirus 2 respiratory infections disproportionately impact patients with hypertension, diabetes, and other cardiovascular comorbidities rather than those with allergic respiratory diseases and immune-compromised conditions. Migraine is a complex neuro-vasculo-inflammatory disorder that is also packed frequently with certain medical conditions including vascular disorders, hypertension, allergic diseases such as asthma and systemic inflammatory disorders. Accordingly, 2 different questions arise during the pandemic (1) Do share comorbidities of cardiovascular diseases and hypertension increase the risk of symptomatic COVID-19 for migraine patients? (2) Do comorbid allergic and atopic diseases, including asthma act as opposite influencers alongside with female gender? This paper focuses on the co-existence of comorbidities of COVID-19, in comparison with migraine, based on a wide clinical dataset and available reports. Discussed mechanisms include potential strategic roles of angiotensin-converting enzyme 2, angiotensin-II, and nucleotide oligomerization domain-like receptor family, pyrin domain containing 3 inflammasome, playing remarkable parts in the pathogenesis of COVID-19 and migraine. There are also some clues about the importance of endothelial and pericyte dysfunction and neuroinflammation in COVID-19 infection, related to complications and survival of the patients. The large epidemiological studies as well as basic research, focusing on migraine patients with COVID-19 will clarify these vital questions during the upcoming periods.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Migraine Disorders Type of study: Observational study / Prognostic study Topics: Long Covid / Variants Limits: Humans Language: English Journal: Headache Year: 2020 Document Type: Article Affiliation country: Head.13998

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Migraine Disorders Type of study: Observational study / Prognostic study Topics: Long Covid / Variants Limits: Humans Language: English Journal: Headache Year: 2020 Document Type: Article Affiliation country: Head.13998